Abstract

Biophoton Quantum Medicine (BQM) represents an emerging and transformative approach in cancer treatment, with potential applications as both a standalone therapy and an adjunct to conventional modalities. Despite progress in oncology, cancer continues to pose a major global health challenge, with persistent issues including therapeutic resistance, systemic toxicity, and compromised patient quality of life. These limitations highlight the urgent need for innovative, non-invasive, and non-toxic therapeutic alternatives. BQM introduces a new paradigm grounded in the coherent application of biophoton energy to enhance mitochondrial function, modulate immune responses, normalize oncogenic gene expression, and restore intercellular communication. This manuscript outlines the scientific rationale, mechanistic underpinnings, clinical observations, preclinical findings, safety profile, regulatory considerations, and prospective research directions related to BQM in oncology. Preliminary data suggest that BQM reduced the adverse effects of cancer therapies, improve patient outcomes, and exert favorable biological influence on tumor processes. Moving forward, robust clinical trials and interdisciplinary research efforts will be critical to establish BQM as a validated component of personalized, quantum-informed cancer care.

Keywords:Biophoton therapy; Cancer adjunct; Quantum medicine; Mitochondrial regulation; Integrative oncology; Energy-based therapy